ATE489963T1 - Chaperonin-10-immunosuppression - Google Patents

Chaperonin-10-immunosuppression

Info

Publication number
ATE489963T1
ATE489963T1 AT03769073T AT03769073T ATE489963T1 AT E489963 T1 ATE489963 T1 AT E489963T1 AT 03769073 T AT03769073 T AT 03769073T AT 03769073 T AT03769073 T AT 03769073T AT E489963 T1 ATE489963 T1 AT E489963T1
Authority
AT
Austria
Prior art keywords
donor
recipient animal
cpn10
administration
host disease
Prior art date
Application number
AT03769073T
Other languages
English (en)
Inventor
Geoffrey R Hill
Tatjana Banovic
Halle Morton
Alice Christina Cavanagh
Original Assignee
Cbio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cbio Ltd filed Critical Cbio Ltd
Application granted granted Critical
Publication of ATE489963T1 publication Critical patent/ATE489963T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03769073T 2002-11-06 2003-11-06 Chaperonin-10-immunosuppression ATE489963T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952492A AU2002952492A0 (en) 2002-11-06 2002-11-06 Chaperonin 10 immunosuppression
PCT/AU2003/001467 WO2004041300A1 (en) 2002-11-06 2003-11-06 Chaperonin 10 immunosuppression

Publications (1)

Publication Number Publication Date
ATE489963T1 true ATE489963T1 (de) 2010-12-15

Family

ID=28795882

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03769073T ATE489963T1 (de) 2002-11-06 2003-11-06 Chaperonin-10-immunosuppression

Country Status (16)

Country Link
US (3) US7618935B2 (de)
EP (3) EP2255824B1 (de)
JP (2) JP4716731B2 (de)
KR (1) KR101088740B1 (de)
CN (1) CN100525832C (de)
AT (1) ATE489963T1 (de)
AU (1) AU2002952492A0 (de)
CA (1) CA2505141C (de)
CY (1) CY1110972T1 (de)
DE (1) DE60335202D1 (de)
DK (1) DK1569679T3 (de)
ES (1) ES2351993T3 (de)
NZ (1) NZ540433A (de)
PT (1) PT1569679E (de)
SI (1) SI1569679T1 (de)
WO (1) WO2004041300A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007517808A (ja) 2004-01-16 2007-07-05 キュビオ リミテッド Ｔｏｌｌ様受容体誘導性のサイトカインおよびケモカイン分泌のシャペロニン１０調節
AU2005204979B2 (en) * 2004-01-16 2010-10-21 Cbio Limited Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
US8036710B2 (en) * 2004-05-07 2011-10-11 Qualcomm, Incorporated Power-efficient multi-antenna wireless device
AU2006269824B2 (en) * 2005-07-11 2012-04-19 Cbio Limited Chaperonin 10-induced immunomodulation
EP1906989A4 (de) 2005-07-11 2009-08-19 Cbio Ltd Durch chaperonin 10 ausgelöste immunmodulation
EP2463307A1 (de) 2005-08-31 2012-06-13 CBIO Limited Modifiziertes Chaperonin 10
AU2006303826B2 (en) * 2005-10-20 2012-07-19 Cbio Limited Treatment of hypersensitivity
CA2626692A1 (en) * 2005-10-20 2007-04-26 Cbio Limited Treatment of hypersensitivity
MX2008011167A (es) 2006-03-02 2008-11-12 Cbio Ltd Regulaciòn de respuestas inmunes mediante la modulaciòn de la funciòn de cèlulas presentadoras de antìgenos.
CA2720617A1 (en) * 2008-04-11 2009-10-15 Cbio Limited Modified cpn10 and prr signalling
US20110243921A1 (en) * 2010-03-30 2011-10-06 Cbio Limited Prevention and treatment of cutaneous lupus erythematosus
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
US10842913B2 (en) 2012-12-10 2020-11-24 Allergan Pharmaceuticals International Limited Scalable three-dimensional elastic construct manufacturing
RU2677637C2 (ru) 2013-08-13 2019-01-18 Эластаджен Пти Лтд Регенерация поврежденной ткани

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176948C (en) * 1993-11-30 2007-05-15 Halle Morton Chaperonin 10
WO1995015338A1 (en) 1993-11-30 1995-06-08 The University Of Queensland Chaperonin 10
US5989804A (en) * 1994-07-08 1999-11-23 New England Medical Center Hospitals, Inc. E6 binding proteins
EP0845994A1 (de) * 1995-08-09 1998-06-10 Schering Corporation Kombinierte anwendung von interleukin-10 und cyclosporin für immunosuppressiontherapie
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
EP1218030A4 (de) 1999-09-10 2004-09-15 Univ Fordham Methoden und zusammensetzungen zur behandlung und prävention von transplantatabstossung durch verwendung von hitzeschockproteinen
GB0028122D0 (en) * 2000-11-17 2001-01-03 St Georges Entpr Ltd Method

Also Published As

Publication number Publication date
CN1735428A (zh) 2006-02-15
US20120082690A1 (en) 2012-04-05
EP1569679A4 (de) 2008-02-27
EP2255824B1 (de) 2014-07-23
EP1569679B1 (de) 2010-12-01
DK1569679T3 (da) 2011-01-10
JP4716731B2 (ja) 2011-07-06
AU2002952492A0 (en) 2002-11-21
EP2255824A1 (de) 2010-12-01
ES2351993T3 (es) 2011-02-14
US7618935B2 (en) 2009-11-17
SI1569679T1 (sl) 2011-01-31
KR101088740B1 (ko) 2011-12-01
CA2505141A1 (en) 2004-05-21
WO2004041300A1 (en) 2004-05-21
PT1569679E (pt) 2010-12-14
EP2818179A1 (de) 2014-12-31
CY1110972T1 (el) 2015-06-11
US8067361B2 (en) 2011-11-29
US20060198834A1 (en) 2006-09-07
NZ540433A (en) 2008-03-28
KR20050086428A (ko) 2005-08-30
DE60335202D1 (en) 2011-01-13
US20100099605A1 (en) 2010-04-22
CN100525832C (zh) 2009-08-12
CA2505141C (en) 2012-07-17
JP2006508099A (ja) 2006-03-09
EP1569679A1 (de) 2005-09-07
JP2011088920A (ja) 2011-05-06

Similar Documents

Publication Publication Date Title
CY1110972T1 (el) Ανοσοκαταστολη με σαπερονινη 10
CY1116107T1 (el) Ενωσεις για χρηση στην αγωγη αυτοανοσων παθησεων, ανοσο-αλλεργικων παθησεων και απορριψης μεταμοσχευσης οργανων ή ιστων
BR0203650A (pt) Estentor de auto-articulação
DE60330468D1 (de) Schweine ohne jegliche expression funktioneller alpha-1,3-galactosyltransferase
ATE463256T1 (de) Mittel zur suppression von transplantat- abstossung
EA200300738A1 (ru) Защита, восстановление и усиление эритропоэтинреактивных клеток, тканей и органов
DK1487431T3 (da) Forebyggelse og/eller behandling af cardiovaskulær sygdom og/eller dermed associeret hjertefejl
PT1404811E (pt) O monóxido de carbono melhora os resultados nos transplantes de tecidos e de orgãos e suprime a apoptose
ES2114888T3 (es) Tratamiento contra el rechazo en el transplante de organos.
EP1676574A3 (de) Verfahren zur Förderung des Überlebens von Zell- und Gewebe-Transplantaten
WO2004039248A3 (en) Repairing or replacing tissues or organs
BR9612821A (pt) Métodos para a prevenção de rejeição de enxerto em transplante e para a produção de uma célula de hospedeiro para terapia genética universal
DK1567171T3 (da) Anvendelse af dextransulfat til behandling af ibmir
NO2019032I1 (no) Treosulfan
WO2004091436A3 (en) Methods and compositions for treating ocular disease
DE60213766D1 (de) Verwendung von beschleunigten lymphozyten zielansteuernden wirkstoffen zur herstellung eines medikaments für die behandlung der verzögertern transplantat-funktion
DE69727948D1 (de) Sordarinderivate
MXPA05004121A (es) Metodos para tratar la enfermedad de ojo reseco con lantibioticos.
DE60023034D1 (en) Cd45 hemmer
ATE238050T1 (de) 4-cyano-4-deformylsordarizin-derivate
BG104258A (en) 4-cyano-4-deformylsordarin derivatives
NO20016326L (no) Anvendelse av proteinet UK 114 for å hindre avstötning av organtransplantatet
HUP0103107A2 (hu) Allogénikus és xenogénikus T-sejtek ex vivo kezelése gp39 antagonistákkal
UA85060C2 (ru) Биологически активная добавка к пище
RU2004128515A (ru) Способ восстановления кожного покрова при комбинированных радиационно-ожоговых поражениях

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1569679

Country of ref document: EP